KRAS mutations in combination with primary tumor size are not associated with a worse prognosis in early Non-Small Cell Lung Cancer https://www.medrxiv.org/content/10.1101/2023.05.02.23289316
KRAS mutations in combination with primary tumor size are not associated with a worse prognosis in early Non-Small Cell Lung Cancer https://www.medrxiv.org/content/10.1101/2023.05.02.23289316